Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy February 23, 2017 Definiens AG To Host International Symposium For Tissue Phenomics April 11, 2017 Genentech’s Frontline Alecensa Approved for Non-Small Cell Lung Cancer November 6, 2017
Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy February 23, 2017
